These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17591872)

  • 21. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice.
    Samolov B; Kvanta A; van der Ploeg I
    Acta Ophthalmol; 2010 Mar; 88(2):251-6. PubMed ID: 19053961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells.
    Ma DH; Tsai RJ; Chu WK; Kao CH; Chen JK
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1822-8. PubMed ID: 10393055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
    Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
    Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential anti-angiogenic role of Slit2 in corneal neovascularization.
    Han X; Zhang MC
    Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of tenascin X gene function impairs injury-induced stromal angiogenesis in mouse corneas.
    Sumioka T; Iwanishi H; Okada Y; Nidegawa Y; Miyajima M; Matsumoto KI; Saika S
    J Cell Mol Med; 2018 Feb; 22(2):948-956. PubMed ID: 29160014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
    Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of trehalose on VEGF-stimulated angiogenesis and myofibroblast proliferation: implications for glaucoma filtration surgery.
    Takeuchi K; Nakazawa M; Ebina Y
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6987-93. PubMed ID: 21778273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
    Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
    Mallet C; Vittet D; Feige JJ; Bailly S
    Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remodeling retinal neovascularization by ALK1 gene transfection in vitro.
    Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.
    Kvanta A; Sarman S; Fagerholm P; Seregard S; Steen B
    Exp Eye Res; 2000 Apr; 70(4):419-28. PubMed ID: 10865990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNFalpha suppression of corneal epithelium migration.
    Okada Y; Ikeda K; Yamanaka O; Miyamoto T; Kitano A; Kao WW; Saika S
    Mol Vis; 2007 Aug; 13():1428-35. PubMed ID: 17768379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
    Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas.
    Kojima T; Chung TY; Chang JH; Sayegh R; Casanova FH; Azar DT
    Cornea; 2007 Jun; 26(5):569-78. PubMed ID: 17525654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro.
    Berthod F; Germain L; Tremblay N; Auger FA
    J Cell Physiol; 2006 May; 207(2):491-8. PubMed ID: 16453301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
    Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
    Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.